Pages

Monday, March 1, 2021

OCGN - Johnson and Johnson Vaccine Approved

Johnson and Johnson Coronavirus vaccine has been approved, and Ocugen stock looks bearish going into April. OCGN hit resistance on the weekly chart. The trend is down, and will likely accelerate down later in March. Weekly

40 comments:

  1. OCGN is very interesting. The company has US rights to a Coronavirus vaccine approved in India called Covaxin.

    ReplyDelete
  2. Covaxin is undergoing phase 3 trials currently.

    ReplyDelete
  3. Results are due fairly soon. Some reports say 2 weeks but I think it may take longer about 5 weeks, probably April.

    ReplyDelete
  4. The stock has some issues short term. A competitor Johnson and Johnson's vaccine was approved this weekend. OCGN is down today.

    ReplyDelete
  5. What makes OCGN most interesting is that as you can imagine there are going to be a lot of ups and downs as Covaxin undergoes Phase 3 trials and approval in the US market.

    ReplyDelete
  6. I love the way this stock trades!

    ReplyDelete
  7. I have big plans for OCGN...

    ReplyDelete
  8. sc,

    so you short into the end of March--and then go long---Correct???

    ReplyDelete
    Replies
    1. Yes generally, or alternatively can wait to enter long at lower levels.

      Delete
    2. I'm not short nor any puts currently

      Delete
  9. At a March 16th meeting Ocugen will ask to increase authorized shares. The company has no money and will need to raise substantial amounts in developing Covaxin.

    "An SEC Form DEFA14A filed today asks shareholders to approve the increase of 95 million shares at a March 16 special meeting as "it is imperative for the future of the company."

    "Given the current level of authorized shares, "we are limited in our abilities to move the company forward in key strategic areas including potentially commercializing COVAXIN in the United States this year, if authorized or approved by the FDA," Musunuri writes.

    ReplyDelete
    Replies
    1. Needless to say this is an issue that will need to be addressed

      Delete
  10. UVXY reaching for fresh lows. Although it did make a decent pop last week you can see why I have been avoiding it.

    ReplyDelete
  11. Thank you for sharing your thoughts. What's your opinion about oil? You mentioned before Oil would be down at the end of Feb but will make a new high until the middle of March. My memory could be wrong though. Do you still think short-term down for oil in the early March?

    ReplyDelete
    Replies
    1. Yes Oil played out as I had thought. The turn came at the end of the month of February. Cooling off this week but stronger next week to make another high. Then bearish Oil from March 14th into an April low due the second week of April.

      Delete
  12. Cramer has a good commentary about vix today.

    ReplyDelete
  13. India's Prime Minister Modi took Covaxin shot today.

    "Prime Minister Narendra Modi on Monday received the first dose of Covid-19 vaccine, Covaxin, indigenously developed by Bharat Biotech International Limited, at the All India Institute of Medical Sciences (AIIMS) in Delhi. The Prime Minister tweeted that he got the first dose and urged those eligible to get vaccinated."

    ReplyDelete
  14. Consolidation day today. Next week should be more exciting.

    ReplyDelete
  15. sc,

    This is the confusing part for next week ---does that mean up or down for the SPX???-------to me--NDX--is lagging and Bond has quieted --anyone that has traded Bonds (treasuries) knows inflation is coming along with more US debt---the fed has little control over this--bonds(treasuries)- interest rates will be higher next month

    ReplyDelete
    Replies
    1. SPX up next week because the market will have hopes for stimulus to pass prior to the deadline of March 14th.

      Delete
    2. The bond market is a theme we will see more concerns over time this year. Not a big problem at the moment.

      Delete
  16. Crude oil goes to 52, no new highs, SC your thoughts

    ReplyDelete
    Replies
    1. Oil turn is coming soon. For the high let's see next week. I do agree Oil is toppy.

      Delete
  17. sc,

    this means a new high next week?

    Thank you!

    ReplyDelete
    Replies
    1. Next week is important. It does have that potential.

      Delete
  18. "Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy"

    ReplyDelete
  19. Took profits on RIG $4.00.

    ReplyDelete
    Replies
    1. Done!

      SCFebruary 19, 2021 at 7:17 AM

      "I think RIG could pop to around $4 short term"

      Delete
  20. SC....

    any charts on bitcoin?

    Thank you

    ReplyDelete
    Replies
    1. My bitcoin charts I am switching to the new chart format.

      Bitcoin could be interesting in short term as it is the favored "stimulus" trade.

      Delete
    2. The deadline is coming next week though and expect it to expire with no stimulus deal.

      Delete
  21. Ocugen I'm glad to see the results and 81% is a good number. However, the US FDA is unlikely to accept these results because it was a foreign trial done in India.

    To apply for US approval Ocugen will likely have to start a US trial, and that will take time.

    ReplyDelete
  22. SPX is a dog this week just as the model predicted. SPX giving up it's gains. Next week should see some better strength.

    ReplyDelete
  23. sc,

    Those rising bonds rates is breaking supports on the NDX, two or three days more this sell off -----is not good?

    ReplyDelete
    Replies
    1. Financials still strong, SPX getting ready to run next week.

      Delete